Toward the discovery of digitalis derivatives with inotropic selectivity
- 1 March 1997
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 2 (3) , 110-116
- https://doi.org/10.1016/s1359-6446(97)01001-5
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Medical advances in the treatment of congestive heart failure.Circulation, 1993
- Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failureThe American Journal of Cardiology, 1992
- Long-term strategies in the management of heart failure: Looking beyond ventricular function and symptomsThe American Journal of Cardiology, 1992
- Current status of non-digitalis positive inotropic drugsThe American Journal of Cardiology, 1992
- Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group.Circulation, 1990
- Inotropic Therapy for Heart FailureNew England Journal of Medicine, 1989
- A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart FailureNew England Journal of Medicine, 1989
- Part I Digitalis glycosides: Mechanisms and manifestations of toxicityProgress in Cardiovascular Diseases, 1984
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.Circulation, 1983